Skip to main content

 Welcome to the Liver Specialists of Texas newsletter of upcoming events, articles, jobs and more from our membership.

 
Yesterday, the FDA give approval to Boceprevir, the first in-class direct acting agent against hepatitis C. This is a long awaited announcement, and great news for patients and providers caring for hepatitis C. A You Tube video is available for review, with Dr. Galati's discussion of how patients will be evaluated and considered for treatment with Boceprevir.
 

 
Boceprevir Receives FDA Approval: A You Tube Video
A You Tube video of the announcement by Dr. Joe Galati is posted, discussing how Liver Specialists of Texas will evaluate and treat both new and old patients with Boceprevir. After years of research, and great anticipation by patients and physicians involved in the care of patients with hepatitis C, Boceprevier was finially approved yesterday. Yesterday was a very important day for those of us involved in the care of patients with hepatitis C, as well as the millions of... [More Info]
 
Conatus Continues New HCV Drug Development
A new financial report by Conatus, a company who is involved with HCV drug development, reports continued investment in their new HCV drugs. We are fortunate that we are conducting studies with their new agents, with good results. For more information, read the blog entry here. 
 
New Hepatitis C Drug, Boceprevir, Features in New England Journal
Dr. Galati posted a blog entry from Berlin where he is attending the European Association for the Study of Liver Disease. Read the entire blog here. 
 
Liver Specialists of Texas Supports The First Colony Dream League
Dr. Galati and Liver Specialists of Texas are 2011 supporters of the First Colony Dream League. First Colony Dream League is a Little League program in Sugar Land, Texas. The Dream League is a division of First Colony Little League (FCLL) and was established in Spring 2007. The Dream League roster is approximately 60 physically- and/or mentally- challenged players. In addition, the league has an Angels in the Outfield program, where approximately 150 teenage boys and girls from Ft.... [More Info]
 
OraSure Technologies Rapid Hepatitis C Test
OraSure Technologies Rapid Hepatitis C Test has been submitted to the FDA for a CLIA waiver, which would allow greater availability to this screening hepatitis C test for those at risk for hepatitis C. Read Dr. Galati's blog entry for more details. 
 
The Five Most Common Questions Liver Transplant Patients Ask Dr. Galati
Dr. Galati recently narrated this You Tube video on The Five Most Common Questions Liver Transplant Patients Ask. If you have additional questions, contact us. 
 
Telaprevir and Boceprevir: FDA Approval Soon
There is great excitement regarding the soon to be FDA approval of both Telaprevir and Boceprevir, in the treatment of chronic heaptitis C. Read here for more information on Dr. Galati's opinion on what will be coming later this summer. 

Stay up to date with our RSS feeds.
 

 


Obesity and Fatty Liver Disease

Obesity, and all of its related complications, is more serious than most adults in America believe. More than one-third (34.9% or 78.6 million) of U.S. adults are obese. Obesity-related conditions include heart disease, stroke, type 2 diabetes, fatty liver disease, and certain types of cancer, are some of the leading causes of preventable death. We are seeing an increase in the number of young children and adolescents developing obesity, and all of the related complications.

The cost of obesity is staggering, with annual medical cost of obesity exceeding $147 billion in 2008 U.S. dollars. The medical costs for people who are obese were $1,429 higher than those of normal weight.

Dr. Galati and the Liver Specialists of Texas team are dedicated to evaluate, treat, and manage all aspects of obesity and non-alcoholic fatty liver disease (NAFLD and NASH), including the complication of cirrhosis and liver failure. Developing a customized plan of care for each patient they see is their objective.

Liver Transplant Resources

Dr. Galati has been involved in Liver Transplantation since 1989. As Medical Director for the Center for Liver Disease and Transplantation at Houston Methodist Hospital, Dr. Galati has cared for thousands of patients with advanced liver disease. In those with the most severe form of advanced liver disease and cirrhosis, liver transplantation is a life-saving surgery. For more information on liver transplantation, click here.

Indications for liver transplant include:

Online LIVER Second Opinion

  • 1

    From the comfort of your home, without the need to spend additional money on travel, lodging, and food, receive and expert second opinion from the expert physicians at Liver Specialists of Texas

  • 2

    There are five steps in the process of requesting a second opinion. We anticipate the steps will take you about 30-65 minutes to complete.

  • 3

    Have your medical records or those of your loved one on hand as you fill out the medical history questionnaire portion of the online process. The medical history questionnaire is detailed so having medical records to quickly reference will help make the process more efficient.

  • 4

    To start the process of an Online Liver Second Opinion, please fill out the initial contact form and fax back to our office. A representative from our office will call you for additional details.